Medicover AB’s Sale of Its Indian Hospital Network to KKR
On 6 August 2026, Medicover AB announced the completion of the sale of its entire Indian hospital operation to KKR & Co. The transaction, valued at approximately 8.1 billion Swedish krona (about $1.4 billion), transferred ownership of 24 hospitals and approximately 4,800 beds that operate across more than 80 clinical specialties in South and West India.
The divestiture was structured as a standalone deal that allows Medicover to focus on its core diagnostic and healthcare services in Europe. KKR, a leading private‑equity firm, will assume control of the Indian network and intends to leverage its existing portfolio to expand further in the country’s rapidly growing healthcare sector.
Following the announcement, Medicover AB’s shares rose sharply, with the closing price on the Stockholm Stock Exchange reaching 223 SEK. The price increase reflected investor confidence in the company’s strategic shift away from a geographically diverse portfolio toward a more concentrated European presence.
The sale proceeds will likely be reinvested in strengthening Medicover’s diagnostic laboratories, clinical clinics, and specialty services across its 10 operating countries. Medicover’s management indicated that the transaction has been fully approved by the company’s board and regulatory authorities.
Medicover’s market capitalization stands at 33.97 billion SEK, with a price‑earnings ratio of 36.15. The company’s 52‑week high and low for 2026 are 278.5 SEK and 179.4 SEK, respectively.
The deal underscores a broader trend of consolidation in the health‑care services sector, as private‑equity firms seek to acquire established hospital operators in emerging markets while allowing European providers to streamline operations and pursue growth in core markets.
